{"transactions":[{"id":718209,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T20:15:27.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":32341,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) July 1, 2027 or (ii) the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":32341,"derivative":{"exercise_price":18.48,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":32341},"source":{"system":"sec-edgar","filing":"0001193125-26-294561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000119312526294561/ownership.xml","form_type":"4"}},{"id":741817,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:47:04.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase shares of the Issuer's common stock, which vests in full on the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continued service to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (\"Fairmount\"), the Reporting Person holds the option for one or more investment vehicles managed by Fairmount (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein."}],"balance_after":34843,"derivative":{"exercise_price":15.22,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":34843},"source":{"system":"sec-edgar","filing":"0001193125-26-267764","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000119312526267764/ownership.xml","form_type":"4"}},{"id":741806,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:23.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000119312526267662/ownership.xml","form_type":"4"}},{"id":828281,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-25T22:01:53.000Z","date":"2026-03-23","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase shares of common stock of the Issuer. This option will vest in equal monthly installments through March 23, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (\"Fairmount\"), the Reporting Person holds the option for one or more investment vehicles managed by Fairmount (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein."}],"balance_after":37313,"derivative":{"exercise_price":23.05,"expiration_date":"2036-03-23","underlying":"Common Stock","underlying_shares":37313},"source":{"system":"sec-edgar","filing":"0001193125-26-124466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000119312526124466/ownership.xml","form_type":"4"}},{"id":1095417,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:48:31.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":21000,"derivative":{"exercise_price":14.47,"expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000950170-25-093118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000095017025093118/ownership.xml","form_type":"4"}},{"id":1121475,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:24:15.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000095017025082368/ownership.xml","form_type":"4"}},{"id":1162519,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-01T22:07:58.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":23017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 23,017 shares of the Issuer's common stock, which vests in full on the earlier of (i) April 29, 2026 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (\"Fairmount\"), the Reporting Person holds the option for one or more investment vehicles managed by Fairmount (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein."}],"balance_after":23017,"derivative":{"exercise_price":10.14,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":23017},"source":{"system":"sec-edgar","filing":"0000950170-25-062102","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000095017025062102/ownership.xml","form_type":"4"}},{"id":1209896,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-12T20:19:43.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 36 equal monthly installments, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":42000,"derivative":{"exercise_price":15.58,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0000950170-25-037965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000095017025037965/ownership.xml","form_type":"4"}},{"id":1480845,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:18:50.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000095017024073238/ownership.xml","form_type":"4"}},{"id":1862566,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:52:44.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":36700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Under the Reporting Person's arrangement with Fairmount Funds Management LLC  (the \"Adviser\"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a \"Fairmount Fund\"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock."}],"balance_after":36700,"derivative":{"exercise_price":11.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":36700},"source":{"system":"sec-edgar","filing":"0000899243-23-014903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000089924323014903/doc4.xml","form_type":"4"}},{"id":2237946,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:09:13.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":30700,"derivative":{"exercise_price":4.59,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0000899243-22-021643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000089924322021643/doc4.xml","form_type":"4"}},{"id":2789429,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T23:00:24.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a three year period."}],"balance_after":60000,"derivative":{"exercise_price":8.45,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-011693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000089924321011693/doc4.xml","form_type":"4"}},{"id":3043865,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":32923,"kind":"person","name":"CAIN CHRISTOPHER W.","position":1,"cik":"0001817733","reported_name":"CAIN CHRISTOPHER W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-08-31T17:01:55.000Z","date":"2020-08-27","kind":"grant","acquired":true,"shares":28661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vest monthly over a three-year period, subject to Director's continued service on the Board."}],"balance_after":28661,"derivative":{"exercise_price":2.77,"expiration_date":"2030-08-27","underlying":"Common Stock","underlying_shares":28661},"source":{"system":"sec-edgar","filing":"0001567619-20-016159","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817733/000156761920016159/doc1.xml","form_type":"4"}}]}